Jefferies Maintains Buy on Structure Therapeutics, Raises Price Target to $125

Benzinga · 3d ago
Jefferies analyst Chris Howerton maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and raises the price target from $79 to $125.